Cargando…

Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox

Clinical guidelines for the treatment of patients with non‐ST‐segment elevation myocardial infarction (NSTEMI) recommend an invasive strategy with cardiac catheterization, revascularization when clinically appropriate, and initiation of dual antiplatelet therapy regardless of whether the patient rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahrens, Ingo, Averkov, Oleg, Zúñiga, Eduardo C., Fong, Alan Y. Y., Alhabib, Khalid F., Halvorsen, Sigrun, Abdul Kader, Muhamad A. B. S. K., Sanz‐Ruiz, Ricardo, Welsh, Robert, Yan, Hongbin, Aylward, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788484/ https://www.ncbi.nlm.nih.gov/pubmed/31317575 http://dx.doi.org/10.1002/clc.23232

Ejemplares similares

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
por: Amin, Arwa M., et al.
Publicado: (2017)

DDT and Malaria Prevention: Addressing the Paradox
por: Bouwman, Hindrik, et al.
Publicado: (2011)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments
por: Toth, Katalin, et al.
Publicado: (2023)

Integrating cognitive and emotion paradigms to address the paradox of aging
por: Carstensen, Laura L.
Publicado: (2018)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
por: O'Brien, Ellen, et al.
Publicado: (2023)

Meta-Analysis Addressing the Efficacy and Safety of Antiplatelet Agents in Patients With COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

The paradox of the life sciences: How to address climate change in the lab
por: Winter, Nikola, et al.
Publicado: (2023)

Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013–19
por: Jortveit, Jarle, et al.
Publicado: (2022)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change
por: Chambers, David A, et al.
Publicado: (2013)

Calibration of cognitive tests to address the reliability paradox for decision-conflict tasks
por: Kucina, Talira, et al.
Publicado: (2023)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Dental management of patients receiving anticoagulant and/or antiplatelet treatment
por: Mingarro-de-León, Ana, et al.
Publicado: (2014)

Significance of antiplatelet therapy in emergency myocardial infarction treatment
por: Komosa, Anna, et al.
Publicado: (2014)

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015)

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
por: Jourdi, Georges, et al.
Publicado: (2021)

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
por: Marcucci, Rossella, et al.
Publicado: (2019)

Complexity of linear relaxations in integer programming
por: Averkov, Gennadiy, et al.
Publicado: (2021)

Paradoxical response to anti-tubercular treatment
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway
por: Jortveit, Jarle, et al.
Publicado: (2021)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

Addressing Reverse Causation Bias in the Obesity Paradox Is Not “One Size Fits All”
por: Tobias, Deirdre K.
Publicado: (2017)

Addressing seeming paradoxes by embracing them: small state theory and the integration of migrants
por: Kolnberger, Thomas, et al.
Publicado: (2021)

Bleeding risk and thrombosis in cirrhosis: a paradox with a need to address them
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Dual antiplatelet treatment after coronary artery bypass surgery
por: Lopez Menendez, Jose, et al.
Publicado: (2015)

Should We Be Afraid of Antiplatelet Treatment before Carotid Endarterectomy?
por: Sucu, Nehir, et al.
Publicado: (2018)

Is antiplatelet treatment effective at attenuating the progression of white matter hyperintensities?
por: Yoon, Cindy W., et al.
Publicado: (2017)

Deep brain stimulation in patients on chronic antiplatelet or anticoagulation treatment
por: Runge, Joachim, et al.
Publicado: (2021)

Heartbeat: the role of antiplatelet therapy in treatment of COVID-19 infections
por: Otto, Catherine M
Publicado: (2022)

Coated Flow Diverters and Single Antiplatelet Treatment: Where are We?
por: Pierot, Laurent
Publicado: (2022)

Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
por: Oliva, Angelo, et al.
Publicado: (2023)

The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox”
por: Kang, Jeehoon, et al.
Publicado: (2018)

How to address ischiofemoral impingement? Treatment algorithm and review of the literature
por: Gollwitzer, Hans, et al.
Publicado: (2017)

Paradoxical Tuberculomas after Completion of Antituberculous Treatment
por: Shah, Ira, et al.
Publicado: (2012)

Cell injury, retrodifferentiation and the cancer treatment paradox
por: Uriel, José
Publicado: (2015)

Autophagy Paradox: Strategizing Treatment Modality in Melanoma
por: Pangilinan, Christian, et al.
Publicado: (2023)

Autophagy: A challengeable paradox in cancer treatment
por: Ahmadi‐Dehlaghi, Farnaz, et al.
Publicado: (2023)

Short- and long-term survival after ST-elevation myocardial infarction treated with pharmacoinvasive versus primary percutaneous coronary intervention strategy: a prospective cohort study
por: Kvakkestad, Kristin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5gpt22ro02su1il1j7945ragmo